Stan
๐ค SpeakerAppearances Over Time
Podcast Appearances
He now practices at Regions Hospitals where he works as hospice medicine physician and a palliative care specialist, assistant professor in the Department of Medicine at the University of Minnesota. And he is currently a co-sponsor of the Regions Health Equity Committee and has a special, special interest in the subject that we're talking about today today. So many, many thanks for being with us.
This is a complicated subject. And I know that you have some great insights. So thank you for being with us, Miguel. I really appreciate it. Clarence.
This is a complicated subject. And I know that you have some great insights. So thank you for being with us, Miguel. I really appreciate it. Clarence.
Here we go. All right, so Clarence and I, and actually all four of us, we've been in the healthcare field a long time. You know, what really is striking to me is, have we had disparities? And if so, why is there so much attention to them now? Or we're hearing about them, at least for sure I am, hearing about them much more today than we did, say, 15, 20 years ago.
Here we go. All right, so Clarence and I, and actually all four of us, we've been in the healthcare field a long time. You know, what really is striking to me is, have we had disparities? And if so, why is there so much attention to them now? Or we're hearing about them, at least for sure I am, hearing about them much more today than we did, say, 15, 20 years ago.
And even then we had them, we had disparities. So what's driving this discussion now?
And even then we had them, we had disparities. So what's driving this discussion now?
Yeah. So, Miguel, you brought up the, you know, actually, you brought up a point that I was thinking, you know, why is it that it's come to the forefront? And you eloquently stated the idea that we have better ways to measure. And that's good. And so... I think we're at this point, we're kind of at this inflection point, it seems to me that, okay, we've had them, we're able to analyze them.
Yeah. So, Miguel, you brought up the, you know, actually, you brought up a point that I was thinking, you know, why is it that it's come to the forefront? And you eloquently stated the idea that we have better ways to measure. And that's good. And so... I think we're at this point, we're kind of at this inflection point, it seems to me that, okay, we've had them, we're able to analyze them.
And then the next question is, what the heck do we do about it? And the next question is, how do we know if we're making a difference? How do we know if we're getting to where we wanna be? So just a reflection on all of that from your perspective.
And then the next question is, what the heck do we do about it? And the next question is, how do we know if we're making a difference? How do we know if we're getting to where we wanna be? So just a reflection on all of that from your perspective.
Yeah, Poy, you really hit the nail on the head. You know, the problem is how we go forward. In previous, in actually quite a few of our shows, we've had a focus or we've asked our guests questions related to prevention, acute treatment, and disease management. Obviously, Miguel, you're saying that that 20%, that 20%,
Yeah, Poy, you really hit the nail on the head. You know, the problem is how we go forward. In previous, in actually quite a few of our shows, we've had a focus or we've asked our guests questions related to prevention, acute treatment, and disease management. Obviously, Miguel, you're saying that that 20%, that 20%,
the healthcare professionals are helping with are basically in the acute treatment and disease management end. And prevention is a hard one. It really is. It's one thing to know what you want to prevent. It's another on exactly how it is that we can go about doing it and maintain it over time. It's not like a one-shot type of thing. Go ahead, Barry.
the healthcare professionals are helping with are basically in the acute treatment and disease management end. And prevention is a hard one. It really is. It's one thing to know what you want to prevent. It's another on exactly how it is that we can go about doing it and maintain it over time. It's not like a one-shot type of thing. Go ahead, Barry.
It's trust. It's an issue of trust.